company background image
FME logo

Fresenius Medical Care Informe acción XTRA:FME

Último precio

€37.79

Capitalización de mercado

€11.1b

7D

3.2%

1Y

-14.2%

Actualizada

26 Apr, 2024

Datos

Finanzas de la empresa +

Fresenius Medical Care AG

Informe acción XTRA:FME

Capitalización de mercado: €11.1b

Resumen de acción FME

Fresenius Medical Care AG ofrece diálisis y servicios relacionados para personas con enfermedades renales en Alemania, Norteamérica e internacionalmente.

FME fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends5/6

Competidores de Fresenius Medical Care AG

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Fresenius Medical Care
Historical stock prices
Current Share Price€37.79
52 Week High€49.62
52 Week Low€30.16
Beta0.93
1 Month Change6.15%
3 Month Change3.05%
1 Year Change-14.19%
3 Year Change-42.88%
5 Year Change-50.48%
Change since IPO130.66%

Noticias y actualizaciones recientes

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Recent updates

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Feb 03
Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?

Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Jan 19
Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Jan 04
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Dec 17
Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt

Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Nov 08
Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think

Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Oct 25
Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 15
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Aug 10
Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively

Rentabilidad de los accionistas

FMEDE HealthcareMercado DE
7D3.2%2.7%0.5%
1Y-14.2%-1.8%1.3%

Rentabilidad vs. Industria: FME obtuvo unos resultados inferiores a los del sector German Healthcare , que el año pasado arrojó un rendimiento del 0.6%.

Rentabilidad vs. Mercado: FME obtuvo unos resultados inferiores a los del mercado German, que fue del 2.3% el año pasado.

Volatilidad de los precios

Is FME's price volatile compared to industry and market?
FME volatility
FME Average Weekly Movement5.7%
Healthcare Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.2%
10% least volatile stocks in DE Market2.4%

Precio estable de las acciones: FME no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de FME (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1996119,845Helen Gizawww.freseniusmedicalcare.com

Fresenius Medical Care AG proporciona diálisis y servicios relacionados para personas con enfermedades renales en Alemania, Norteamérica e internacionalmente. La empresa ofrece tratamiento de diálisis y servicios relacionados de laboratorio y diagnóstico a través de una red de clínicas de diálisis ambulatorias; materiales, formación y servicios de apoyo al paciente que comprenden la supervisión clínica, la asistencia de seguimiento y la organización de la entrega de los suministros en el domicilio del paciente; y servicios de diálisis bajo contrato con hospitales de Estados Unidos para los pacientes hospitalizados con enfermedad renal en fase terminal (ESRD) y para pacientes que sufren insuficiencia renal aguda. También desarrolla, fabrica y distribuye diversos productos sanitarios, como dializadores de polisulfona, máquinas de hemodiálisis, cicladoras de diálisis peritoneal, soluciones de diálisis peritoneal, concentrados, soluciones y granulados de hemodiálisis, líneas sanguíneas, productos farmacéuticos renales, sistemas para el tratamiento del agua y productos cardiopulmonares agudos y de aféresis.

Resumen de fundamentos de Fresenius Medical Care AG

¿Cómo se comparan los beneficios e ingresos de Fresenius Medical Care con su capitalización de mercado?
Estadísticas fundamentales de FME
Capitalización bursátil€11.09b
Beneficios(TTM)€499.00m
Ingresos (TTM)€19.45b

22.2x

Ratio precio-beneficio (PE)

0.6x

Ratio precio-ventas (PS)

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de FME
Ingresos€19.45b
Coste de los ingresos€14.53b
Beneficio bruto€4.93b
Otros gastos€4.43b
Beneficios€499.00m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

May 07, 2024

Beneficios por acción (BPA)1.70
Margen bruto25.32%
Margen de beneficio neto2.57%
Ratio deuda/patrimonio53.3%

¿Cómo se ha desempeñado FME a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

3.1%

Rentabilidad actual por dividendo

70%

Ratio de pagos
¿Cuándo hay que comprar FME para recibir un próximo dividendo?
fechas de dividendos de Fresenius Medical Care
Fecha ex dividendoMay 17 2024
Fecha de pago de dividendosMay 22 2024
Días hasta ex dividendo20 days
Días hasta la fecha de pago de dividendos25 days